Thomas Tüting

Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis

J. Landsberg, T. Tüting, P. Zigrino, 2017, Oncogene.

Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS

K. Kähler, F. Meier, D. Göppner, 2023, Melanoma research.

Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice

E. Gaffal, D. Schanze, A. Braun, 2024, Cancer gene therapy.

Melanoma Vaccines

T. Tüting, Thomas Tüting, 2014 .